Diagnosing and treating anxiety comorbidity in bipolar disorders

Psychiatric Annals

Volumn 34, Issue 11, 2004, Pages 874-884

  Goldberg, Joseph F ^a   Fagin Jones, Stephanie ^a  

^a ZUCKER HILLSIDE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; BUSPIRONE; ETIRACETAM; FLUOXETINE; GABAPENTIN; GLUCOCORTICOID; GLUCOSE; LAMOTRIGINE; LITHIUM; NEUROLEPTIC AGENT; NORADRENALIN; PAROXETINE; PREGABALIN; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; TIAGABINE; TOPIRAMATE; VALPROATE SEMISODIUM;

ALCOHOL ABUSE; ANXIETY DISORDER; BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; BRAIN METABOLISM; CHROMOSOME 18Q; CINGULATE GYRUS; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; CONFERENCE PAPER; CORRELATION ANALYSIS; DEPRESSION; DISEASE SEVERITY; DIZZINESS; GENERALIZED ANXIETY DISORDER; GLUCOSE TRANSPORT; HEALTH SURVEY; HEREDITY; HIPPOCAMPUS; HUMAN; INSULA; MANIA; MOOD DISORDER; NEUROANATOMY; NEUROIMAGING; NEUROPHYSIOLOGY; OBSESSIVE COMPULSIVE DISORDER; ONSET AGE; PANIC; PATIENT COMPLIANCE; POSTTRAUMATIC STRESS DISORDER; PROGNOSIS; QUALITY OF LIFE; SEX DIFFERENCE; SOCIAL PHOBIA; SOCIAL STATUS; SOMNOLENCE; SUBSTANCE ABUSE; SUICIDAL BEHAVIOR; TREATMENT OUTCOME;

EID: 8844266875     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/0048-5713-20041101-16     Document Type: Conference Paper

References (101)

1. McElroy SL, Altshuler LL, Suppes T, et al. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry. 2001;158(3):420-426.
2. Hirschfeld RM, Lewis L, Vornik LA. Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder. J Clin Psychiatry. 2003;64(2):161-174.
3. Tamam L, Ozpoyraz N. Comorbidity of anxiety disorder among patients with bipolar I disorder in remission. Psychopathology. 2002;35(4):203-209.
4. Boylan KR, Bieling PJ, Marriott M, et al. Impact of comorbid anxiety disorders on outcome in a cohort of patients with bipolar disorder. J Clin Psychiatry. 2004;65(8):1106-1113.
5. Simon NM, Otto MW, Wisniewski SR, et al. Anxiety disorder comorbidity in bipolar disorder: data from the first 500 STEP-BD participants. Am J Psychiatry. In press.
6. Kessler RC, Rubinow DR, Holmes C, Abelson JM, Zhao S. The epidemiology of DSM-III-R bipolar I disorder in a general population survey. Psychol Med. 1997;27(5):1079-1089.
7. Regier DA, Narrow WE, Rae DS. The epidemiology of anxiety disorders: the Epidemiologic Catchment Area (ECA) experience. J Psychiatr Res. 1990;24(Suppl 2):3-14.
8. Boyd JH, Burke JD Jr, Gruenberg E, et al. Exclusion criteria of DSM-III. A study of the co-occurrence of hierarchy-free syndromes. Arch Gen Psychiatry. 1984;41(10):983-989.
9. Henry C, Van den Bulke D, Bellivier F, et al. Anxiety disorders in 318 bipolar patients: prevalence and impact on illness severity and response to mood stabilizer. J Clin Psychiatry. 2003;64(3):331-335.
10. Young LT, Cooke RG, Robb JC, et al. Anxious and non-anxious bipolar disorder. J Affect Disord. 1993;29(1):49-52.
11. Perugi G, Akiskal HS. The soft bipolar spectrum redefined: focus on the cyclothymic, anxious-sensitive, impulse dyscontrol, and binge-eating connection in bipolar II and related conditions. Psychiatr Clin N Amer. 2002;25(4):713-737.
12. Perugi G, Akiskal HS, Ramacciotti S, et al. Depressive comorbidity of panic, social phobic, and obsessive-compulsive disorder reexamined: is there a bipolar II connection? J Psychiatr Res. 1999;33(1):53-61.
13. Akiskal HS. The prevalent clinical spectrum of bipolar disorders: beyond DSM-IV. J Clin Psychopharmacol. 1996;16(Suppl 1):4S-14S.
14. Himmelhoch JM. Social anxiety, hypomania and the bipolar spectrum: data, theory and clinical issues. J Affect Disord. 1998;50(2-3):203-213.
15. Strakowski SM, Tohen M, Stoll AL, et al. Comorbidity in mania at first hospitalization. Am J Psychiatry. 1992;149(4):554-556.
16. Keck PE Jr., McElroy SL, Strakowski SM, et al. Twelve-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. Am J Psychiatry. 1998;155(5):646-652.
17. Faedda GL, Baldessarini RJ, Glovinsky IP, et al. Pediatric bipolar disorder: phenomenology and course of illness. Bipolar Disord. 2004;6(4):305-313.
18. Perlis R, Miyahara S, Marangell LB, et al.; STEP-BD Investigators. Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry. 2004;55(9):875-881.
19. Cassano GB, Pini S, Saettoni M, Dell'Osso L. Multiple anxiety disorder comorbidity in patients with mood spectrum disorders with psychotic features. Am J Psychiatry. 1999;156(3):474-476.
20. Perugi G, Akiskal HS, Toni C, Simonini E, Gemignani A. The temporal relationship between anxiety disorders and (hypo)mania: a retrospective examination of 63 panic, social phobic and obsessive-compulsive patients with comorbid bipolar disorder. J Affect Disord. 2001;67(1-3):199-206.
21. Dilsaver SC, Chen YW. Social phobia, panic disorder and suicidality in subjects with pure and depressive mania. J Affect Disord. 2003;77(2):173-177.
22. Shoaib AM, Dilsaver SC. Panic disorder in subjects with pure mania and depressive mania. Anxiety. 1994-1995;1(6):302-304.
23. Edmonds LK, Mosley BJ, Olds RJ, et al. Familial bipolar disorder: preliminary results from the Otago familial bipolar genetic study. Aust NZ J Psychiatr. 1998;32(6):823-829.
24. MacKinnon DF, McMahon FJ, Simpson SG, McInnis MG, DePaulo JR. Panic disorder with familial bipolar disorder. Biol Psychiatry. 1997;42(2):90-95.
25. Perugi G, Akiskal HS, Ramacciotti S, et al. Depressive comorbidity of panic, social phobic, and obsessive-compulsive disorders reexamined: is there a bipolar II connection? J Psychiatr Res. 1999;33(2):53-61.
26. MacKinnon DF, Zandi PP, Cooper J, et al. Comorbid bipolar disorder and panic disorder in families with a high prevalence of bipolar disorder. Am J Psychiatry. 2002;159(1):30-35.
27. MacKinnon DF, Xu J, McMahon FJ, et al. Bipolar disorder and panic disorder in families: an analysis of chromosome 18 data. Am J Psychiatry. 1998;155(6):829-831.
28. Benazzi F. Bipolar II disorder family history using the family history screen: findings and clinical implications. Compr Psychiatr. 2004;45(2):77-82.
29. Wozniak J, Biederman J, Monuteaux MC, Richards J, Faraone SV. Parsing the comorbidity between bipolar disorder and anxiety disorders: a familial risk analysis. J Child Adolesc Psychopharmacol. 2002;12(2):101-111.
30. Coryell W, Endicott J, Andreasen N, Keller M. Bipolar I, bipolar II, and nonbipolar major depression among the relatives of affectively ill probans. Am J Psychiatry. 1985;142(7):817-821.
31. Klein DN, Depue RA. Obsessional personality traits and risk for bipolar affective disorder: an offspring study. J Abnorm Psychol. 1985;94(3):291-297.
32. Coryell W. Obsessive-compulsive disorder and primary unipolar depression. Comparisons of background, family history, course, and mortality. J Nerv Ment Dis. 1981;169(4):220-224.
33. Osuch EA, Ketter TA, Kimbrell TA, et al. Regional cerebral metabolism associated with anxiety symptoms in affective disorder patients. Biol Psychiatry. 2000;48(10):1020-1023.
34. Swann AC, Secunda SK, Koslow SH, et al. Mania: sympathoadrenal function and clinical state. Psychiatry Res. 1991;37(2):195-205.
35. Elhaj O, Youngstrom EA, Sakai HE, et al. The prevalence of bipolar and comorbid disorders in the Ottawa County Jail. New Research Poster No. 45 presented at the 157th Annual Meeting of the American Psychiatric Association; May 1-6, 2004: New York, NY.
36. Leverich GS, McElroy SL, Suppes T, et al. Early physical and sexual abuse associated with an adverse course of bipolar illness. Biol Psychiatry. 2002;51(4):288-297.
37. Chen YW, Dilsaver SC. Co-morbidity of panic disorder in bipolar illness: evidence from the Epidemiologic Catchment Area Survey. Am J Psychiatry. 1995;152(2):280-282.
38. Simon NM, Smoller JW, Fava M, et al. Comparing anxiety disorders and anxiety-related traits in bipolar disorder and unipolar depression. J Psychiatr Res. 2003;37(3):187-192.
39. Savino M, Perugi G, Simonini E, et al. Affective comorbidity in panic disorder: is there a bipolar connection? J Affect Disord. 1993; 28(3):155-163.
40. Pini S, Dell'Osso L, Amador XF, et al. Awareness of illness in patients with bipolar I disorder with or without comorbid anxiety disorders. Aust NZ J Psychiatry 2003;37(3):355-361.
41. Frank E, Cyranowski JM, Rucci P, et al. Clinical significance of lifetime panic spectrum symptoms in the treatment of patients with bipolar I disorder. Arch Gen Psychiatry. 2002;59(10):905-911.
42. Feske U, Frank E, Mallinger AG, et al. Anxiety as a correlate of response to the acute treatment of bipolar I disorder. Am J Psychiatry. 2000;157(6):956-962.
43. Simon NM, Otto MW, Weiss RD, et al. Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD. J Clin Psychopharmacol. 2004;24(5):512-520.
44. Wittchen HU, Zhao S, Kessler RC, et al. DSM-III-R generalized anxiety disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51(5):355-364.
45. Yerevanian BI, Koek RV, Ramdev S. Anxiety disorders comorbidity in mood disorder subgroups: data from a mood disorders clinic. J Affect Disord. 2001;67(1-3):167-173.
46. Judd LL, Akiskal HS, Schettler PJ, et al. The comparative clinical phenotype and long term longitudinal episode course of bipolar I and II: a clinical spectrum or distinct disorders? J Affect Disord. 2003;73(1-2):19-32.
47. Pini S, Cassano GB, Simonimi E, et al. Prevalence of anxiety disorder comorbidity in bipolar disorder, unipolar depression, and dysthymia. J Affect Disord. 1998;42(2-3):145-153.
48. Lensi P, Cassano GB, Correddu GP, et al. Obsessive-compulsive disorder. Familial-developmental history, symptomatology, comorbidity, and course with special reference to gender-related differences. Br J Psychiatry. 1996;169(1):101-107.
49. Masi G, Perugi G, Toni C, et al. Obsessive-compulsive bipolar comorbidity: focus on children and adolescents. J Affect Disord. 2004;78(3):175-183.
50. Perugi G, Akiskal HS, Pfanner C, et al. The clinical impact of bipolar and unipolar affective comorbidity on obsessive-compulsive disorder. J Affect Disord. 1997;46(1):15-23.
51. Fogarty F, Russell JM, Newman SC, et al. Epidemiology of psychiatric disorders in Edmonton. Mania. Acta Psychiatr Scand Suppl. 1994;376:16-23.
52. Kruger S, Cooke RG, Hasey GM, et al. Comorbidity of obsessive compulsive disorder in bipolar disorder. J Affect Disord. 1995;34(2):117-120.
53. Chen Y-W, Dilsaver SC. Comorbidity for obsessive-compulsive disorder in bipolar and unipolar disorders. Psychiatry Res. 1995;59(1-2):57-64.
54. Schneier FR, Blanco C, Antia SX, Liebowitz MR. The social anxiety spectrum. Psych Clin N Amer. 2002;25(4):757-774.
55. Perugi G, Akiskal HS, Toni C, Simonini E, Gemignani A. The temporal relationship between anxiety disorders and (hypo)mania: a retrospective examination of 63 panic, social phobic, and obsessive-compulsive patients with comorbid bipolar disorder. J Affect Disord. 2001;67(1-3):199-206.
56. Perugi G, Frare F, Toni C, Mata B, Akiskal HS. Bipolar II and unipolar comorbidity in 153 outpatients with social phobia. Compr Psychiatry. 2001;42(5):375-381.
57. Kessler RC, Stang P, Wittchen HU, Stein M, Walters EE. Lifetime comorbidities between social phobia and mood disorders in the U.S. National Comorbidity Survey. Psychol Med. 1999;29(3):555-567.
58. Johnson JJ, Weissman MM, Klerman GL. Panic disorder, comorbidity, and suicide attempts. Arch Gen Psychiatry. 1990;47(9):805-808.
59. Goodwin RD, Stayner DA, Chinman MJ, et al. The relationship between anxiety and substance use disorders among individuals with severe affective disorders. Compr Psychiatry. 2002;43(4):245-252.
60. Sasson Y, Chopra M, Harrari E, Amitai K. Zohar J. Bipolar comorbidity: from diagnostic dilemmas to therapeutic challenge. Intl J Neuropsychopharmacol. 2003;6(2):139-144.
61. Scott J, Pope M. Nonadherence with mood stabilizers: prevalence and predictors. J Clin Psychiatry 2002;63(5):384-390.
62. Prien RF, Himmelhoch JM, Kupfer DJ. Treatment of mixed mania. J Affect Disord. 1988;15(1):9-15.
63. Post RM, Frye MA, Denicoff KD, et al. Beyond lithium in the treatment of bipolar illness. Neuropsychopharmacol. 1998;19(3):206-219.
64. Nemeroff CB. The role of GABA in the pathophysiology and treatment of anxiety disorders. Psychopharmacol Bull. 2003;37(4):133-146.
65. Otte C, Wiedemann K, Yassouridis A, Kellner M. Valproate monotherapy in the treatment of civilian patients with non-combat-related posttraumatic stress disorder: an open-label study. J Clin Psychopharmacol. 2004;24(1):106-108.
66. Baetz M, Bowen RC. Efficacy of divalproex sodium in patients with panic disorder and mood instability who have not responded to conventional therapy. Can J Psychiatry. 1998;43(1):73-77.
67. Hertzberg MA, Butterfield MI, Feldman ME, et al. A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder. Biol Psychiatry. 1999;45(9):1226-1229.
68. Ernst CE, Goldberg JE. Antidepressant properties of anticonvulsant drugs for bipolar disorder. J Clin Psychopharmacol. 2003;23(2):182-192.
69. Berlant J, van Kammen DP. Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report. J Clin Psychiatry. 2002;63(1):15-20.
70. Frye MA, Ketter TA, Kimbrell TA, et al. A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol. 2000;20(6):607-614.
71. Pande AC, Crockatt JG, Janney CA, Werth JL, Tsaroucha G. Gabapentin in bipolar disorder : a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorders Study Group. Bipolar Disord. 2000;2(3 pt. 2):249-255.
72. Pande AC, Davidson JR, Jefferson JW, et al. Treatment of social phobia with gabapentin: a placebo-controlled study. J Clin Psychopharmacol. 1999;19(4):341-348.
73. Pande AC, Pollack MH, Crockatt J, et al. Placebo-controlled study of gabapentin treatment of panic disorder. J Clin Psychopharmacol. 2000;20(4):461-467.
74. Cora-Locatelli G, Greenberg BD, Martin J, Murphy DL. Gabapentin augmentation for fluoxetine-treated patients with obsessive-compulsive disorder. J Clin Psychiatry. 1998;59(9):480-481.
75. Perugi G, Toni C, Frare F, et al. Effectiveness of adjunctive gabapentin in resistant bipolar disorder: is it due to anxious-alcohol abuse comorbidity? J Clin Psychopharmacol. 2002;22(6):584-591.
76. Sills GJ. Pre-clinical studies with the GABAergic compounds vigabatrin and tiagabine. Epileptic Disord. 2003;5(1):51-56.
77. Grunze H, Erfurth A, Marcuse A, et al. Tiagabine appears not to be efficacious in the treatment of acute mania. J Clin Psychiatry. 1999;60(11):759-762.
78. Suppes T, Chisholm KA, Dhavale D, et al. Tiagabine in treatment refractory bipolar disorder: a clinical case series. Bipolar Disord. 2002;4(5):283-289.
79. Rosenthal M. Tiagabine for the treatment of generalized anxiety disorder: a randomized, open-label, clinical trial with paroxetine as a positive control. J Clin Psychiatry. 2003;64(10):1245-1249.
80. Schwartz TL. The use of tiagabine augmentation for treatment-resistant anxiety disorders: a case series. Psychopharmacol Bull. 2002;36(2):53-57.
81. Fink K, Dooley DJ, Meder WP, et al. Inhibition of neuronal Ca2+ influx by gabapentin and pregabalin in the human neocortex. Neuropharmacol. 2002;42(2):229-236.
82. Pande AC, Feltner DE, Jefferson JW, et al. Efficacy of the novel anxiolytic pregabalin in social anxiety disorder : a placebo-controlled, multicenter study. J Clin Psychopharmacol. 2004;24(2):141-149.
83. Feltner DE, Crockatt JG, Dubovsky SJ, et al. A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder. J Clin Psychopharmacol. 2003;23(3):240-249.
84. Lynch BA, Lambeng N, Nocka K, et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA. 2004;101(26):9861-9866.
85. Simon NM, Worthington JJ, Doyle AC, et al. An open-label study of levetiracetam for social anxiety disorder. J Clin Psychiatry. 2004;65(9):1219-1222.
86. McIntyre R, Katzman M. The role of atypical antipsychotics in bipolar depression and anxiety disorders. Bipolar Disord. 2003;5(Suppl 2):20-35.
87. Denys D, de Geus F, van Megen HJ, Westenberg HD. A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors. J Clin Psychiatry. 2004;65(8):1040-1048.
88. Filteau MJ, Leblanc J, Bouchard RH. Quetiapine reduces flashbacks in chronic posttraumatic stress disorder. Can J Psychiatry. 2003;48(4):282-283.
89. Sokolski KN, Denson TF, Lee RT, Reist C. Quetiapine for treatment of refractory symptoms of combat-related posttraumatic stress disorder. Mil Med. 2003;168(6):486-489.
90. Hollander E, Baldini Rossi N, Sood E, Pallanti S. Risperidone augmentation in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. Int J Neuropsychopharmacol. 2003;6(4):397-401.
91. Van Ameringen M, Allgulander C, Bandelow B, et al. WCA recommendations for the long-term treatment of social phobia. CNS Spectr. 2003;8(8 Suppl 1):40-52.
92. Vieta E, Bernardo M. Antidepressant-induced mania in obsessive-compulsive disorder. Am J Psychiatry. 1992;149(9):1282-1283.
93. Scott J. Treatment outcome studies. In: Johnson S, Leahy R, eds. Psychological Treatment of Bipolar Disorders. New York, NY: Guilford Press; 2004:226-241.
94. Jones S. Psychotherapy of bipolar disorder: A review. J Affect Disord 2002;80(2-3)101-114.
95. Zaretsky A. Targeted psychosocial interventions for bipolar disorder. Bipolar Disord 2003;5(Suppl 2),80-87.
96. Clark DM. Panic disorder: from theory to therapy. In: Salkovskis PM, ed. Frontiers of Cognitive Therapy. New York, NY: Guilford Press, 1996:318-344.
97. Borovec TD, Whisman MA. Psychosocial treatments for generalized anxiety disorder. In: Mavissakalian MR, Prien RF, eds. Long-term Treatments of Anxiety Disorders. Washington. DC: American Psychiatric Publishing; 1996: 171-199.
98. Heimberg RG, Juster HR. Cognitive-behavioral treatments: literature review. In: Heimberg RG, Leibowitz MR, Hope DA, Schneier FR, eds. Social phobia: Diagnosis, Assessment, and Treatment. New York, NY: Guilford Press; 1995:261-309.
99. Taylor S. Meta-analysis of cognitive-behavioral treatments for social phobia. J Behav Ther Exp Psychiatry. 1996;27(1):1-9.
100. Foa EB, Kozak MJ, Steketee GS, McCarthy PR Treatment of depression and obsessive-compulsive symptoms in OCD by imipramine and behaviour therapy. Br J Clin Psychol. 1992;31(part 3):279-292.
101. Foa EB, Rothbaum BO, Molnar C. Cognitive-behavioral therapy of post-traumatic stress disorder. In Friedman MJ, Charney DA, Deutch AY (Eds.), Neurobiological and Clinical Consequences of Stress: From Normal Adaptation to PTSD. Philadelphia, PA: Lippineott-Raven; 1995:483-494.